Honour to pioneer of nuclear medicine production
Michael Druce has been awarded a Public Service Medal in the Australia Day honours for his contribution to nuclear medicine production.
Showing 41 - 60 of 168 results
Michael Druce has been awarded a Public Service Medal in the Australia Day honours for his contribution to nuclear medicine production.
Originally from Switzerland, Dr Häusermann gained his PhD in x-ray diffraction and synchrotron techniques at King’s College London.
The 2023 Australian Synchrotron Stephen Wilkins Thesis Medal has been awarded to Dr Yanxiang Meng from the Walter & Eliza Hall Institute for Medical Research and the University of Melbourne for his research investigating the molecular mechanism at work in a form of programmed cell death, which is implicated in a variety of inflammatory diseases.
ANSTO’s Australian Synchrotron has been working on an initiative that could substantially improve radiotherapy treatment for cancer patients.
$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.
Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.
The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
The User Advisory Committee (UAC) are pleased to present this year's invited speakers.
Professor of Soil Science at The University of Queensland, Peter Kopittke and partner investigator Prof Enzo Lombi of the University of SA are very optimistic about the use of a new synchrotron-based imaging technique that captures in 3D the complex interaction of soil and root.
The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.
Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron neutron capture therapy, a promising radiation therapy for treating aggressive cancers.
First Asia Oceania Forum held at the Australian Synchrotron
(ANSTO) has welcomed the launch of the new National Science Statement and revitalised National Science and Research Priorities by Minister for Industry and Science, The Hon Ed Husic MP and Australia’s Chief Scientist, Dr Cathy Foley AO PSM.
The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian company Mediso Pacific.
With enhanced submicron spatial resolution, speed and contrast, the Micro-Computed Tomography beamline opens a window on the micron-scale 3D structure of a wide range of samples relevant to many areas of science including life sciences, materials engineering, anthropology, palaeontology and geology. MCT will be able to undertake high-speed and high-throughput studies, as well as provide a range of phase-contrast imaging modalities.